About
Intratech Medical is developing the Booster balloon catheter therapy to treat patients with acute myocardial infarction by reducing infarct size, thereby improving clinical outcomes. The Booster balloon aims to disrupt the last frontier in ischemic heart disease management and to improve the lives of millions of people worldwide while lowering the associated healthcare costs. Each year approximately 16 million people worldwide will have a heart attack caused by the narrowing or blockage of the coronary arteries supplying blood to the heart muscle. About 6 million of these patients will have an acute myocardial infarction (AMI) requiring immediate revascularization of the clogged artery, which is performed by percutaneous coronary intervention (PCI). Even after a successful revascularization of the patients coronary arteries, in up to 30% of patients the ischemic area around the infarcted heart muscle may still grow and convert into scar tissue, resulting in higher rates of heart failure and mortality. Intratech Medical has had promising preclinical results and is launching its first-in-human clinical study in 2021.
Funding history · 1 round · — total
Company Intelligence Q&A
Structured intelligence from startupim data — optimized for AI retrieval and grounding.
- What is Intratech Medical's primary focus?
- Intratech Medical is developing the Booster balloon catheter therapy to treat patients with acute myocardial infarction by reducing infarct size.
- When was Intratech Medical founded?
- Intratech Medical was founded in October 2007.
- What is the current operational status of Intratech Medical?
- Intratech Medical is currently inactive and ceased to operate in August 2025.
- Which product is Intratech Medical developing for acute myocardial infarction?
- Intratech Medical is developing the Booster balloon catheter therapy.
- When did Intratech Medical conduct its first-in-human clinical study?
- Intratech Medical launched its first-in-human clinical study in 2021.
- What was Intratech Medical's last known funding round?
- Intratech Medical's last known funding round was a Series A in December 2007, with XT Venture Capital as a lead investor.
- How many employees does Intratech Medical have?
- Intratech Medical has 1-10 employees, with an exact count of 2.
- Where is Intratech Medical headquartered?
- Intratech Medical is headquartered in Shefayim, Israel.